Breaking News
29 minutes ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
CDSCO shifts early drug testing entry from formal approval to digital prior intimation via the NSWS portal, compressing timelines for sponsors and CDMOs.
Pharma Now Editorial Team

Merck's pumitamig update at AACR 2026 signals renewed PD-pathway competition, with manufacturing and CMC implications for late-stage oncology pipelines.
Pharma Now Editorial Team

Eli Lilly acquires Kelonia Therapeutics for $7B, securing in vivo CAR-T capabilities and signaling a shift in ATMP manufacturing strategy.
Pharma Now Editorial Team

FDA accepts Roche sBLA for obinutuzumab in SLE based on ALLEGORY phase III data; decision expected December 2026.
Pharma Now Editorial Team
